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ABSTRACT
Hippo pathway downstream effectors Yap and Taz play key roles in cell proliferation and regen-
eration, regulating gene expression especially via Tead transcription factors. To investigate their
role in skeletal muscle stem cells, we analyzed Taz in vivo and ex vivo in comparison with Yap.
Small interfering RNA knockdown or retroviral-mediated expression of wild-type human or con-
stitutively active TAZ mutants in satellite cells showed that TAZ promoted proliferation, a func-
tion shared with YAP. However, at later stages of myogenesis, TAZ also enhanced myogenic
differentiation of myoblasts, whereas YAP inhibits such differentiation. Functionally, while mus-
cle growth was mildly affected in Taz (gene Wwtr1–/–) knockout (KO) mice, there were no overt
effects on regeneration. Conversely, conditional KO of Yap in satellite cells of Pax7Cre-ERT2/1:
Yapﬂ8x/ﬂ8x: Rosa26Lacz mice produced a marked regeneration deﬁcit. To identify potential mecha-
nisms, microarray analysis showed many common TAZ/YAP target genes, but TAZ also regulates
some genes independently of YAP, including myogenic genes such as Pax7, Myf5, and Myod1
(ArrayExpress–E-MTAB-5395). Proteomic analysis revealed many novel binding partners of TAZ/
YAP in myogenic cells, but TAZ also interacts with proteins distinct from YAP that are often
involved in myogenesis and aspects of cytoskeleton organization (ProteomeXchange–
PXD005751). Neither TAZ nor YAP bind members of the Wnt destruction complex but both regu-
lated expression of Wnt and Wnt-cross talking genes with known roles in myogenesis. Finally,
TAZ operates through Tead4 to enhance myogenic differentiation. In summary, Taz and Yap have
overlapping functions in promoting myoblast proliferation but Taz then switches to enhance
myogenic differentiation. STEM CELLS 2017; 00:000–000
SIGNIFICANCE STATEMENT
Hippo pathway effectors Yap and Taz play key roles in cell proliferation and tissue growth. We
analyzed Taz in comparison with Yap in muscle stem cells. Taz promoted proliferation, a func-
tion shared with Yap. However, Taz also enhanced differentiation into myotubes, unlike Yap.
Muscle growth was affected in Taz (Wwtr1–/–) knockout (KO) mice, while KO of Yap produced a
clear regeneration deficit. Taz regulates some genes independently of Yap, and Taz also interacts
with proteins distinct from Yap, mainly involved in myogenesis/cytoskeleton. In particular, Taz
operates through Tead4 to enhance differentiation. In summary, Taz and Yap have overlapping
functions in promoting myoblast proliferation but later, Taz also enhances myogenic
differentiation.
INTRODUCTION
Transcriptional cofactors Yap (Yap1) and Taz
(Wwtr1) mainly regulate gene expression by
binding Tead1–4 transcription factors. Together
Yap, Taz, and Teads are the nexus of the Hippo
signal transduction network that includes the
Hippo kinase cascade, comprising kinases Mst1
(Stk4), Mst2 (Stk3), Lats1, and Lats2 [1–3].
Many other signaling modules also regulate
Yap and Taz activity, such as mechanotransduc-
tion [4], glucose-signaling [5], GPCR [6], Wnt
[7–9], Smad [10, 11], Notch [12], Pten-Akt-
mTOR [13–16], and Lkb1-Ampk [17–20]. Yap
and Taz are inhibited by phosphorylation of
multiple HXRSS motifs by Lats1/2, which pro-
motes localization to the cytosol, 14–3-3 bind-
ing, and degradation [3, 21]. Yap Ser127 and
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Taz Ser89 are key phosphorylation sites, and mutations at
Ser127 or Ser89 to alanine in Yap S127A and Taz S89A pre-
vent phosphorylation at these residues and result in constitu-
tive activity.
Signaling modules involving Yap/Taz control skeletal mus-
cle myogenesis and adaptation to exercise. Tead transcription
factors bind CATTCC/GGAATG (MCAT or GTIIC motifs) often
found near promoters of cardiac and skeletal muscle genes [3,
22], and by binding enhancers [23, 24]. However, Tead1 binds
muscle genes repressed in rhabdomyosarcoma [25], consistent
with observation that Yap and Taz can also repress gene
expression [26].
Satellite cells are responsible for postnatal skeletal muscle
growth, hypertrophy, and repair/regeneration [27], and we
have shown that Yap promotes proliferation of myoblasts [28,
29] but inhibits myogenic differentiation. YAP1 S127A expres-
sion in activated, but not quiescent, satellite cells causes
embryonal rhabdomyosarcoma-like tumours with short latency
and 100% penetrance [25]. Expression of YAP1 S127A in mus-
cle ﬁbers causes myopathy [30], whereas other types of Yap
delivery or Yap mutants can cause hypertrophy [31, 32], with
outcome likely dependent on Yap levels.
Taz harbors the same functionally important WW and
Tead-binding domains as Yap and often acts as a paralogue,
but not always [2, 3]. This is demonstrated by Yap or Taz KO
mice: while Yap KO causes early embryonic lethality [33], 50%
of Taz (Wwtr1) KO mice are viable but develop glomerulocys-
tic kidney disease [34]. Earlier reports suggest that Yap and
Taz also have divergent functions in the skeletal muscle line-
age: both Yap and Taz promote skeletal muscle ﬁber hypertro-
phy and regeneration [35, 36], but only Taz promotes fusion
into multinucleated myotubes [29, 37, 38].
The distinct functions of YAP and TAZ are poorly under-
stood, so we investigated their regulation, function, target
genes, and binding partners in murine myoblasts. Taz and Yap
have overlapping functions in promoting satellite cell prolifer-
ation. However, later in myogenesis, Taz enhances myogenic
differentiation and fusion, a function not shared by Yap. Taz
(Wwtr1–/–)-null mice had no overt muscle regeneration phe-
notype, unlike mice with conditional KO of Yap in satellite
cells. To understand mechanism, we examined gene expres-
sion, and found, for example, that YAP and TAZ both alter
expression of multiple Wnt pathway genes. In addition to
common targets, TAZ also regulates a separate set of genes
from YAP during myogenesis, including myogenic factors Pax7,
Myf5, and MyoD. Using proteomics to identify binding part-
ners of TAZ and YAP, we discovered both common and distinct
interactors, with TAZ binding proteins that regulate myogene-
sis and aspects of cytoskeleton organization. Finally, we found
that TAZ operates through Tead4 in myoblasts to enhance
myogenic differentiation.
MATERIALS AND METHODS
Animals
Taz (Wwtr1)-KO (Jax, stock 011120) and Yapﬂ/ﬂ mice are
described [39, 40]. Pax7Cre mice were purchased from Jax
(stock 012476). Pax7Cre:Yapﬂ/ﬂ:R26-ﬂoxstop-LacZ [9] mice were
donated by Fernando Camargo. Breeding/experimental proce-
dures were approved by the Ethical Review Process
Committee of KCL, and performed under the Animals (Scien-
tiﬁc Procedures) Act 1986.
Cell Culture
Satellite cells/myoﬁbers were isolated as described previously
[41]. Brieﬂy, murine extensor digitorum longus (EDL) myoﬁb-
ers were isolated by 0.05% type I collagenase for 2 hours.
Myoﬁbers were washed in GlutaMax Dulbecco’s modiﬁed
Eagle’s medium (DMEM) (ThermoFisher Scientiﬁc) and plated
on matrigel-coated plates in growth medium (GlutaMax
DMEM, 30% fetal bovine serum [FBS], 1% chick embryo
extract [CEE], 10 ng/mL basic ﬁbroblast growth factor, 1%
penicillin-streptomycin) at 378C with 5% CO2. After 72 hours,
myoﬁbers were removed, and satellite cells passaged and pre-
plated for 30 minutes to remove ﬁbroblasts, before being
plated on matrigel-coated plates. Differentiation was induced
in differentiation medium (GlutaMax DMEM, 2% horse serum,
1% penicillin–streptomycin). Nonadherent cultures: myoﬁbers
were cultured in GlutaMax DMEM, 10% horse serum, 0.5%
CEE, 1% penicillin–streptomycin.
Muscle Injury
To recombine via loxP sites ﬂanking Yap exons 1 and 2, 200
mg of Tamoxifen/gram body weight (Sigma T5648) was
injected intraperitoneally in sunﬂower oil/5% ethanol for 3
consecutive days, followed by maintenance on a tamoxifen-
containing diet (Tekland). Injury was induced in tibialis ante-
rior (TA) by 30 mL intramuscular injection of 20 mM cardio-
toxin (CTX)/saline.
Retroviral Expression and Small Interfering RNA
Wild-type (WT) TAZ, TAZ S89A, YAP S127A, or WT YAP was
subcloned into a pMSCV-IRES-eGFP retroviral expression back-
bone (Addgene Plasmids 24809, 24815, 17791 and 17790)
creating pMSCV-3xFlag TAZ-IRES-eGFP and pMSCV-3xFlag-TAZ
S89A-IRES-eGFP [42]. Empty vector was negative control. Ret-
roviruses were packaged in HEK293T cells using standard
methods. Medium was changed 1 hour before transfection/
transduction. Retroviral suspension diluted 1:4 with polybrene
(4 lg/mL) was added for 6 h, before changing medium.
Taz small interfering RNA (siRNA) (Ambion, s97145) and
Yap siRNA (Ambion, s202423) were used as per manufac-
turer’s instructions. For plated satellite cells, 25 pmol of siRNA
with Lipofectamine RNAiMax (ThermoFisher Scientiﬁc) was
added to each well for either 6 hours (satellite cells) or 24
hours (C2C12) before medium was changed.
Real-Time Quantitative Polymerase Chain Reaction
Total RNA was extracted with RNeasy (Qiagen) and reverse tran-
scribed using QuantiTect reverse transcription (Qiagen) as per
manufacturer’s instructions. Real-time quantitative polymerase
chain reaction (RT-qPCR) was performed with Brilliant II SYBR
green reagents and a ROX reference dye (Stratagene) using the
ViiA7 qPCR system. Primer sequences were Yap (50-TGAGCC
CAAGTCCCACTC-30; R-50-TGTGAGTGTCCCAGGAGAAA-30), Taz
(50-TATCCCAGCCAAATCTCGTG-30, R-50-TTCTGCTGGCTCAGGGTAC
T-30) or as described [43].
Immunolabeling and EdU Pulsing
Cells/myoﬁbers were ﬁxed with 4% paraformaldehyde (PFA)/
phosphate-buffered saline (PBS) for 10 minutes, permeabilized
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with 0.5% Triton-X100/PBS and blocked with 10% goat serum/
PBS or 0.035% carrageenan/PBS followed by incubation with
antibodies overnight at 48C [41]. Antibodies: anti-Pax7 (DSHB);
anti-myosin heavy chain (MyHC) (MF20, DSHB); anti-myogenin
(F5D, DSHB); anti-MyoD (clone 5.8A, DakoCytomation); anti-
Taz (HPA007415, Sigma); anti-Yap1 (2F12, Abnova); anti-Tead4
(M01, Abnova).
Cryosections were ﬁxed with 4% PFA/PBS followed by cooled
methanol before antigen retrieval in heated citrate buffer [44]
and blocking in 10% goat serum/PBS. Antibodies: anti-MyHC
Type I (BA-D5, DSHB), anti-MyHC Type IIa (A4.74, DSHB), and
anti-laminin (Sigma, L9393). Fluorochrome-conjugated second-
ary antibodies were from ThermoFisher Scientiﬁc.
5-Ethyl-20-deoxyuridine (EdU) (10 mM) was added for 2 hours
before ﬁxation and incorporation detected using Click-iT (Thermo-
Fisher Scientiﬁc) according to manufacturer’s instructions.
Western Blotting
Western blotting was performed using Run Blue precast
native Page gels (Expedeon). Protein transfer was performed
with the XCell II blot module (ThermoFisher Scientiﬁc). PVDF
membranes were incubated with antibodies overnight/48C
and visualized using ﬂuorochrome-conjugated secondary anti-
bodies (ThermoFisher Scientiﬁc) and digitally imaged.
Mass Spectrometry
C2C12 cells were grown in DMEM (D5761) with 10% FBS and
4 mM glutamine. Proliferating C2C12 cells were at 50% cell
density. Conﬂuent cultures were differentiated for 72 hours in
DMEM, 2% horse serum, 4 mM glutamine.
For immunoprecipitation, 80,000 C2C12s were seeded per
10 cm dish. The following day, fresh medium was added 1
hour before addition of 1:5 diluted TAZ or YAP encoding retro-
viral supernatant. The next day, cells were replated and trans-
duction conﬁrmed by green ﬂuorescent protein (GFP). Cells
were washed on ice with PBS, and collected in lysis buffer
(150 mM NaCl, 20 mM Tris-HCl pH 7.5, 1% Triton 3100) with
1 mM sodium orthovanadate, protease inhibitor cocktail
(Sigma, p8340), and PMSF. Lysates were incubated for 1 hour
on ice and centrifuged at 14,000 RPM at 48C for 5 minutes
and supernatant incubated at 48C with anti-Flag M2 agarose
beads (Sigma). Beads were washed three times with washing
buffer (150 mM NaCl; 20 mM Tris-HCL pH 7.5). Sample prepa-
ration/mass spectrometry were as described [45], with prote-
omics data deposited to the ProteomeXchange Consortium via
the PRIDE [46] partner repository: identiﬁer PXD005751.
Microarray
Total RNA was isolated from TAZ S89A or YAP S127A trans-
duced myoblasts after 24 or 48 hours using TRIzol (Thermo-
Fisher Scientiﬁc) followed by puriﬁcation and DNase digestion
(RNeasy minikits, Qiagen). RNA quantiﬁcation was performed
on a Nanodrop spectrophotometer (ThermoFisher Scientiﬁc)
and quality tested on an Agilent Tapestation (RIN 7.6–9.8).
Generation of sense strand cDNA, second strand synthesis, in
vitro transcription cRNA synthesis, single stranded cDNA syn-
thesis and RNA hydrolysis, fragmentation, and labeling were
as manufacturer’s instructions (GeneChip WT Plus reagent kit,
Affymetrix). Hybridization, washing, staining, and scanning of
microarrays were carried out on Affymetrix Mouse Gene 2.0
ST microarrays using a GeneChip Fluidics station 450 and
GCS3000 scanner (AffymetrixV
R
).
Data preprocessing/quality control were performed using
AffymetrixV
R
GenechipV
R
Expression Console v1.2. Probe cell
intensity data (CEL ﬁles) were processed using the RMA16
algorithm (Affymetrix), which ﬁts a linear model at probe
level by using background correction, quantile normalization
of log2 transformed data, and summarization, for primary QC
analysis. Performed in triplicate at Centre for Genome
Enabled Biology and Medicine (University of Aberdeen).
Data were analyzed in PartekV
R
Genomics SuiteV
R
, version
6.6, build 6.15.0730 Copyright; 2014 (Partek Inc.) using a
Mouse Gene 2.0 ST annotation ﬁle from build mm10,
MoGene-2.0-st-v1.na35.mm10.transcript. Affymetrix CEL ﬁles
were imported to PartekV
R
Genomics SuiteV
R
, data processed
using RMA normalization with RMA background correction
and quantile normalization of log2 transformed data and pro-
beset summarization by median polish. Two-way analysis of
variance (ANOVA) with time point (24 and 48 hours) and tran-
scription factor (Control, TAZ S89A, YAP S127A) and
time 3 transcription interaction to evaluate signiﬁcantly dif-
ferentially expressed genes. Fold change in TAZ S89A or YAP
S127A compared with control vector as baseline at each time
point calculated using geometric mean of samples in each
group with signiﬁcance calculated by Fishers Least signiﬁcant
difference. Fold change 1.3 and FDR of 10% were evaluated.
Microarray data available in the ArrayExpress database (www.
ebi.ac.uk/arrayexpress), accession number E-MTAB-5395.
Histology
H&E and ATPase staining were described previously [30]. Mus-
cle sections were stained with ATPase at pH 4.47 to detect
type I, and pH 10.5 to detect type II, myoﬁbers.
Image Acquisition and Analysis
Images were obtained at room temperature on a Zeiss micro-
scope (Axiovert 200M) equipped with LD A-plan 203/0.85
ph1, 103/0.30ph1 and 403/.075ph1 objectives or on a Zeiss
Exciter laser scanning microscope (LSM) with 403/1.1 W Corr
LD C-Apochromat objective. Images were quantiﬁed with
image J software (NIH). Neonatal MyHC labeling was quanti-
ﬁed with R software. Values are mean6 SEM with a Student’s
t test (paired or unpaired as appropriate) or ANOVA with a
post-hoc Tukey’s test for >2 groups.
RESULTS
Taz Is Dynamically Regulated during Myogenic
Progression
To assess Yap and Taz expression dynamics during muscle
regeneration, we measured mRNA levels by RT-qPCR in vivo
and myogenic progression in vitro. Murine TA muscle was
injured by intramuscular injection of CTX and mRNA isolated
from regenerating muscle after 1, 3, 5, 7, and 14 days post-
injury (dpi). Taz mRNA increased markedly at 3 dpi compared
with uninjured control, before dropping, while Yap was largely
unchanged (Fig. 1A). Taz mRNA rose during differentiation of
C2C12 myoblasts, while Yap mRNA remained relatively con-
stant (Fig. 1B). Western blot analysis for total Yap and Taz pro-
tein in C2C12 reﬂected mRNA dynamics, with Taz levels rising
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Figure 1. Taz levels increase during skeletal muscle regeneration and myogenic differentiation. (A): Yap and Taz mRNA expression in
regenerating tibialis anterior (TA) muscle collected at 1, 3, 5, 7, and 14 days post injury. Expression is fold change compared with control
undamaged TA (n 5 3). (B): Yap and Taz mRNA levels in C2C12 myoblasts at 24 and 48 hours in proliferation medium, and 24, 48, 72,
and 96 hours in differentiation medium, expressed as fold change compared with 24 hours proliferation time-point (n 5 3). (C): Repre-
sentative Western blots from biological replicate 4 (n 5 4) showing total Yap, Taz, and phosphorylated Yap and Taz levels in C2C12 myo-
blasts at 24 and 48 hours in proliferation medium, and 24, 48, 72, and 96 hours in differentiation medium, with relevant a-Tubulin or
Gapdh loading controls. (D): Taz mRNA increased through differentiation in plated satellite cell-derived myoblasts at 12, 24, and 48
hours. Data are mean 6 SEM from three experiments where an asterisk denotes signiﬁcant difference (p < .05) from 0 hour using an
unpaired Student’s t test. (E): C2C12 proliferating myoblasts coimmunolabeled for Yap and Taz. (F): Plated satellite cell-derived myoblasts
coimmunolabeled with MyoD and Taz after 36 hours ex vivo. (G): Plated satellite cell-derived myotubes coimmunolabeled with myoge-
nin and Taz after 48 hours ex vivo. (H): Confocal images of satellite cells coimmunolabeled with MyoD and Taz on isolated ﬁbers cul-
tured ex vivo for 72 hours; arrow points to Taz-containing nuclei. Scale bar5 100 mm (F, G). Abbreviation: DAPI, 40,6-diamidino-2-
phenylindole.
during differentiation, while Yap again remained relatively
constant (Fig. 1C). Phosphorylated Yap and Taz levels both
showed an increase during myogenic differentiation. Taz
mRNA also increased during ex vivo differentiation of plated
murine satellite cell-derived myoblasts (Fig. 1D).
Coimmunolabeling C2C12 myoblasts for Yap and Taz
revealed Taz localized to the cytoplasm and nucleus, while
Yap was nuclear (Fig. 1E), consistent with our previous obser-
vations [29]. Taz was similarly localized in satellite cells (Fig.
1F), but became cytoplasmic in mature multinucleated myo-
tubes (Fig. 1G). Coimmunolabeling of satellite cells in their
niche on a myoﬁber showed that Taz was expressed in satel-
lite cells as shown by MyoD coexpression (Fig. 1H).
Taz Promotes Myoblast Proliferation
To compare Taz with Yap function, we either increased Taz
activity via retroviral-mediated expression of human TAZ or
constitutively active TAZ S89A, or after decreasing Taz and/or
Yap levels using siRNA and performed proliferation and differ-
entiation assays.
The retroviral backbone contains an IRES-eGFP that allows
transduced cells to be identiﬁed by eGFP. Immunolabeling
revealed that TAZ or TAZ S89A signiﬁcantly increased the pro-
portion of eGFP1 ve cells that had incorporated EdU, indicat-
ing that TAZ increases proliferation (Fig. 2A, 2B). siRNA-
knockdown of Taz, Yap, or both Taz/Yap, however, signiﬁcantly
reduced EdU incorporation (Fig. 2C, 2D). Thus, at this stage,
TAZ promotes proliferation of myoblasts, as we reported pre-
viously for YAP [28, 29].
RT-qPCR showed that siRNA-mediated knockdown of Taz
suppressed Myf5 and myogenin expression, but enhanced
Pax7. Conversely, knockdown of Yap increased myogenin
expression, but reduced Pax7 and Myf5. Simultaneous knock-
down of both Taz and Yap rescued expression of myogenin
(Fig. 2E).
Taz and Yap Play Opposing Roles during Myogenic
Differentiation
We determined the effect of retroviral-mediated constitutive
expression of TAZ or TAZ S89A on early myogenic differentia-
tion in satellite cells cultured in their niche for 72 hours on
an isolated myoﬁber, by coimmunolabeling for eGFP/Pax7 to
mark undifferentiated/self-renewing cells (Fig. 3A) or eGFP/
myogenin to mark myoblasts entering differentiation (Fig. 3B).
TAZ signiﬁcantly decreased eGFP-containing self-renewing
Pax71 ve cells (Fig. 3A), while TAZ or TAZ S89A signiﬁcantly
increased eGFP-containing differentiating myogenin 1ve myo-
blasts (Fig. 3B), compared with control. Thus, TAZ promotes
entry into differentiation, at the expense of satellite cell self-
renewal.
To investigate effects of TAZ or TAZ S89A throughout myo-
genic differentiation, we used expanded, plated satellite cell-
derived myoblasts, which were ﬁrst transduced and then
switched to differentiation medium 24 hours later. Self-
renewal and differentiation were again assessed by coimmu-
noﬂuorescence for eGFP/Pax7 and eGFP/myogenin. Under dif-
ferentiation stimulus, TAZ or TAZ S89A decreased the
proportion of myocytes expressing Pax7, while enhancing the
proportion expressing myogenin (Fig. 3C, 3D). At this early
stage of differentiation, myotubes were also more prominent
in myoblast cultures transduced with TAZ or TAZ S89A, than
control retrovirus, suggesting a time-dependent switch of TAZ
function from proproliferation to prodifferentiation (Fig. 3E).
At later stages of differentiation and fusion into multinucle-
ated myotubes, constitutive expression of TAZ or TAZ S89A
also increased incorporation of nuclei into myotubes (fusion
index - Fig. 3F, 3G). siRNA-mediated Taz knockdown in
expanded plated satellite cell-derived myoblasts did not signif-
icantly reduce (though p5 .06) the fusion index to below con-
trol levels (Fig. 3H, 3I).
Taz (Wwtr1–/–)-Null Myoblasts Differentiate Less Ex
Vivo
Skeletal muscles of Taz (Wwtr1–/–)-KO mice have not been
well-characterized [40]. Consistent with the trend in siRNA
data (Fig. 3H, 3I), satellite cells isolated and expanded from
Taz (Wwtr1–/–)-null mice fused less into post-mitotic myo-
tubes compared with WT cells (Fig. 3J, 3K).
Thus, Taz promotes proliferation of myoblasts, but at later
stages of myogenesis, Taz switches to enhance differentiation,
while, as we reported previously, Yap continues to promote
proliferation while inhibiting differentiation [28, 29].
Taz (Wwtr1–/–)-Null Mice Have Fewer Myofibers in
Soleus
In accordance with the role of the Hippo pathway in body/
organ size regulation, 6-week-old Taz (Wwtr1–/–)-KO mice
were lighter than WT mice (Fig. 4A) as were their TA, soleus,
EDL, and gastrocnemius muscles (Fig. 4B–4E). However, the
number of satellite cells and myonuclei per EDL myoﬁber was
unchanged between Taz (Wwtr1–/–)-null and WT mice (Fig. 4F,
4G). Myoﬁber type composition in soleus was analyzed using
ATPase activity at pH 4.47 to detect slow type I, or pH 10.5
to detect fast type IIa, myoﬁbers. Soleus contained fewer
muscle ﬁbers in total, with both numbers of type I and type
IIa myoﬁbers signiﬁcantly reduced compared with WT (Fig.
4H, 4I), but the proportion of slow type I myoﬁbers was sig-
niﬁcantly increased, while the proportion of type IIa were sig-
niﬁcantly decreased, compared with control WT. Myoﬁber
cross-sectional area was unchanged though (Fig. 4J).
Next, we investigated muscle regeneration in the Taz
(Wwtr1–/–)-KO mice using intra-muscular injection of CTX into
TA. Cryosections of 5 dpi regenerating TA were immunola-
beled for neonatal MyHC to identify regenerating myoﬁbers,
but Taz (Wwtr1–/–)-KOs did not exhibit a reduction compared
with controls (Fig. 4K, 4L). At 10 dpi, the number of myoﬁbers
with centrally located nuclei in TA of Taz (Wwtr1–/–)-null mice
was also unchanged (Fig. 4M, 4N).
Inactivation of Yap in Satellite Cells Impairs Muscle
Regeneration
Administration of Tamoxifen to Pax7Cre-ERT2/1:Yapﬂ8x/ﬂ8x:
Rosa26Lacz mice causes Pax7-driven Cre-ERT2-mediated dele-
tion of Yap exons 1 and 2 in satellite cells, with simultaneous
induction of lacZ expression. Pax7Cre-ERT2/1:Yapﬂ8x/ﬂ8x:
Rosa26Lacz and age-matched control Pax7Cre-ERT2/1: Yapﬂ8x/1:
Rosa26Lacz mice were given three intraperitoneal injections of
Tamoxifen, and then maintained on tamoxifen-containing
food. TA muscles were injured by intramuscular injection of
CTX, and regenerating muscles cryosectioned at 5 and 10 dpi
(Fig. 5A).
Sun, De Mello, Mohamed et al. 5
www.StemCells.com VC 2017 The Authors
STEM CELLS published by Wiley Periodicals, Inc. on behalf of AlphaMed Press
Regenerating TA muscles at 5 dpi from Tamoxifen-treated
Pax7Cre-ERT2/1:Yapﬂ8x/ﬂ8x:Rosa26Lacz mice coimmunolabeled for
neonatal MyHC and laminin had a 30% smaller area contain-
ing neonatal MyHC than control Pax7Cre-ERT2/1:Yapﬂ8x/1:
Rosa26Lacz (Fig. 5B, 5C). Immunolabeling for Pax7 revealed
that there was a nonsigniﬁcant (p5 .054) trend to reduced
numbers of satellite cells in Tamoxifen-treated 5 dpi regener-
ating Pax7Cre-ERT2/1:Yapﬂ8x/ﬂ8x:Rosa26Lacz muscle (Fig. 5D, 5F).
By 10 dpi, Pax7 immunolabeling revealed that satellite cell
number in tamoxifen-treated Pax7Cre-ERT2/1:Yapﬂ8x/ﬂ8x:
Figure 2. Taz controls satellite cell-derived myoblast proliferation. (A): Representative images of 5-ethyl-20-deoxyuridine (EdU) incorpora-
tion in satellite cell-derived myoblasts 48 hours following transduction with control vector, or retroviral constructs encoding wild-type
human TAZ or constitutively active TAZ S89A, where green ﬂuorescent protein (GFP) marks transduced cells. (B): Quantiﬁcation of GFP1 cells
with EdU incorporation shows that TAZ or TAZ S89A signiﬁcantly increases EdU incorporation, and so proliferation rate (n 5 5 mice). (C):
Representative images of EdU incorporation in satellite cell-derived myoblasts following Yap and/or Taz knockdown using siControl, siYap,
siTaz, or siYap 1 Taz transfection. (D): Quantiﬁcation of EdU incorporation shows that knockdown of Yap, Taz, or both Yap and Taz reduces
the proliferation rate (n 5 5 mice). (E): Relative gene expression measured by real-time quantitative polymerase chain reaction in satellite
cell-derived myoblasts compared with si Control under proliferation conditions following siControl, siYap, siTaz, or siYap 1 Taz knockdown,
normalized to Gapdh (n 5 5 mice except for myosin heavy chain/MyoD, where n 5 3). Data presented as mean 6 SEM, where an asterisk
denotes signiﬁcant difference from control retrovirus/control small interfering RNA (p < .05) using Student’s t test. Scale bar5 100 mm.
Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; EdU, 5-ethyl-2’-deoxyuridine; GFP, green ﬂuorescent protein; RV, control vector.
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Rosa26Lacz mice was as in control Pax7Cre-ERT2/1:Yapﬂ8x/1:
Rosa26Lacz mice (Fig. 5E, 5F). The number of myoﬁbers with
centrally located myonuclei, a hallmark of regenerated muscle,
was also unchanged between Pax7Cre-ERT2/1:Yapﬂ8x/ﬂ8x:
Rosa26Lacz regenerating TA muscles and control (Fig. 5G, 5H).
Thus, lack of Yap function in satellite cells slows, but does not
prevent, muscle regeneration.
YAP and TAZ Regulate the Hippo Negative Feedback
Loop, Myogenic Regulators, and Wnt Signaling
To compare the effects of TAZ and YAP on gene expression in
the skeletal muscle lineage, we expressed TAZ S89A or
YAP1 S127A in proliferating murine satellite cell-derived
myoblasts for 24 and 48 hours and analyzed gene expression
by microarray (Supporting Information Data 1), comparing our
observations with those obtained by induction of YAP1 S127A
in myoblasts derived from a transgenic mouse model [29] and
from rhabdomyosarcomas driven by YAP1 S127A [25].
Combination of 24 and 48 hours time points revealed that
TAZ S89A signiﬁcantly changed expression of 860 genes, while
YAP S127A altered expression of 294 genes, with an additional
316 genes regulated by both TAZ S89A and YAP S127A (Fig.
6A; Supporting Information Data 1). Satellite cells were
already actively proliferating as cultured in high serum
medium, and serum is a potent YAP activator [47], likely
explaining why neither TAZ S89A nor YAP1 S127A signiﬁcantly
Figure 3. Taz regulates fusion of satellite cell-derived myoblasts. (A, B): Satellite cells on isolated myoﬁbers were transduced with retro-
viruses encoding wild-type (WT) human TAZ, constitutively active TAZ S89A or Control vector (RV), and cultured ex vivo for 72 hours,
before being coimmunolabeled for eGFP and Pax7, or eGFP and Myogenin. Quantiﬁcation of the proportion of (A) green ﬂuorescent pro-
tein (GFP)/Pax7 and (B) GFP/myogenin satellite cells in the ex vivo cultures after 72 hours (n 5 3 mice). (C, D): Quantiﬁcation of the
proportion of expanded plated satellite cell-derived myoblasts transduced with control retroviral vector, WT human TAZ, or TAZ S89A
and incubated in differentiation medium for 24 hours before being coimmunolabeled as myocytes for eGFP/Pax7 or eGFP/myogenin,
illustrated in (E) (n 5 4 mice). (F): Representative images of expanded plated satellite cell-derived myoblasts transduced with WT human
TAZ, TAZ S89A, or RV and incubated in differentiation medium before being coimmunolabeled for eGFP/myosin heavy chain (MyHC). (G):
Quantiﬁcation of the proportion of nuclei within GFP/MyHC myotubes shows that TAZ or TAZ S89A increases myogenic fusion (n 5 5
mice). (H): Representative images of satellite cell-derived myoblasts transfected with small interfering RNA (siRNA) control or siRNA Taz
and immunolabeled for MyHC after 24 hours. (I): Quantiﬁcation shows a trend toward reduced fusion (p 5 .06) with siRNA Taz (n 5 3
mice). (J): Representative images of myotubes formed from satellite cell-derived myoblasts isolated from WT (Wwtr11/1) or Taz
(Wwtr1–/–)-knockout (KO) mice after 24 hours in differentiation medium. (K): Quantiﬁcation reveals less fusion in the Taz (Wwtr1–/–) KO
mice compared with controls (n 5 4 per genotype). Data are mean 6 SEM, where an asterisk denotes signiﬁcant difference (p < .05)
using a Student’s t test from RV/control siRNA/Wwtr11/1 as appropriate. Scale bars5 100mm. Abbreviations: GFP, green ﬂuorescent pro-
tein; MyHC, myosin heavy chain; RV, control vector; siRNA, small interfering RNA.
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affected most mitotic genes, in contrast to earlier observa-
tions [25, 29].
Increased TAZ/YAP-Tead activity was indicated by both TAZ
S89A and YAP S127A inducing the Hippo negative feedback
loop genes Amotl2, Frmd6 (Willin), and Lats2, which was pre-
sumably to limit Taz/Yap activity. TAZ S89A and YAP S127A
also regulate markers/regulators of the muscle lineage: Caveo-
lin1 (Cav1) was upregulated, while Six1 and Six4 were down-
regulated. In addition, TAZ and YAP regulated multiple
members of the mTOR/insulin-like growth factor (IGF)
pathway, including Igfbp5, as well as Ndrg2 and Irs2, which
regulate mTOR via Akt (Fig. 6B).
Wnts are TAZ/YAP regulators, and TAZ/YAP regulation of
Wnt and Wnt-related proteins can inhibit Wnt signaling [48].
TAZ S89A and YAP S127A altered expression of key Wnt path-
way regulators, reducing expression of Wnt-receptor proteins
Fzd7 and Lgr5, while TAZ S89A alone suppressed expression
of Fzd6, Lgr4, and Lgr6, suggesting that TAZ/YAP desensitize
myoblasts to ligands that bind these receptors. Moreover, TAZ
S89A increased expression of Wnt4, and altered expression of
Figure 4. Characterization of skeletal muscle and muscle regeneration in Taz (Wwtr1–/–) knockout (KO) mice. (A): Body weight of 6-
week-old Taz (Wwtr1–/–) KO (Taz KO) mice (n 5 7) compared with wild-type (WT) Wwtr11/1 control (n 5 9). (B–E): Quantiﬁcation of
muscle weight of tibialis anterior (TA), Soleus, extensor digitorum longus (EDL), and Gastrocnemius from WT and Taz KO mice (n 5 3
mice). (F): Satellite cell and (G): myonuclei number per myoﬁber isolated from the EDL of WT or Taz KO mice (n 5 4 mice of each geno-
type). (H): Representative images of soleus from 6-week-old WT and Taz KO after ATPase histochemical staining at pH 4.47 to show slow
type I (dark) and fast type IIa (light/no stain) muscle ﬁber types. (I): Quantiﬁcation showing less total myoﬁbers in the soleus of Taz KO
mice, with numbers of both type I and type IIa reduced (n 5 3 mice of each genotype). (J): Quantiﬁcation of cross section area of type
I and type IIa reveals that myoﬁbers from Taz KO are unchanged compared with controls (n 5 3 mice per genotype). (K): Representative
images and (L): quantiﬁcation of the proportion of the neonatal myosin heavy chain (MyHC) area of regenerating TA myoﬁbers coimmu-
nolabeled for neonatal MyHC (NeoMyHC)/laminin at 5 days post injury (dpi) with CTX (n 5 4 mice of each genoptype). (M): Representa-
tive images of H&E staining at 10 dpi of TA from Taz KO and WT mice. (N): Quantiﬁcation of the number of myoﬁbers with a central
nucleus per ﬁeld of 10 dpi TA (n 5 3 mice per genotype). Data are mean 6 SEM where an asterisk denotes signiﬁcant difference
(p < .05) between WT and Taz KO using a Student’s t test. Scale bar5 100 mm. Abbreviations: CSA, cross section area; EDL, extensor
digitorum longus; KO, knockout; MyHC, myosin heavy chain; TA, tibialis anterior; WT, wild type.
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other secreted Wnt-associated proteins and genes encoding
the structurally related proteins Wisp1 and Wisp2 [49]. Addi-
tionally, both TAZ S89A and YAP S127A decreased Sox9
expression (Fig. 6B, 6C).
TAZ Regulates a Unique Set of Genes
Although the microarray was performed on proliferating myo-
blasts, genes regulated by TAZ only might explain the func-
tional switch from proproliferation to prodifferentiation (Fig.
6C). Both Pax7 and MyoD were downregulated by TAZ S89A
while Myf5 was upregulated, consistent with Taz siRNA knock-
down (Fig. 2E). Upregulated cell junction proteins could con-
tribute to enhanced fusion capability in TAZ-overexpressing
myoblasts, since N-Cadherin is required for myoblast fusion
[50]. TAZ overexpression also altered expression of olfactory
receptors Olfr311 and Olfr1086 (Fig. 6C), a family of genes
engaged in satellite cell self-renewal [51]. Mki67 (protein
Ki67) involved in proliferation, but was downregulated by TAZ
Figure 5. Yap conditional knockout (KO) in satellite cells affects muscle regeneration. (A): Time course for analysis of Yap conditional
KO and control mice after tamoxifen administration via intraperitoneal injection and food, and cardiotoxin (CTX)-induced injury. (B, C):
Representative images and quantiﬁcation of tibialis anterior (TA) cryosections 5 dpi after CTX injury of Pax7CreERT/1:Yapﬂ8x/ﬂ8x:Rosa26Laz
(Pax7Cre Yapﬂ/ﬂ) and control Pax7CreERT/1:Yap ﬂ8x/1:Rosa26Laz (Pax7Cre Yapﬂ/1) mice, coimmunolabeled for neonatal myosin heavy
chain (MyHC) (NeoMyHC)/laminin to identify regenerating myoﬁbers (n 5 4 mice per genotype). (D–F): Representative images and
quantiﬁcation of cryosections of TA muscles after 5 or 10 dpi, immunolabeled for Pax7 to label satellite cells (5 dpi: n 5 4 per genotype;
10 dpi: n 5 4 Pax7Cre Yapﬂ/ﬂ and n 5 3 Pax7Cre Yapﬂ/1). (G): Representative images of H&E staining and (H) quantiﬁcation of cen-
trally nucleated myoﬁber number per ﬁeld of 10 dpi TA. Data are mean 6 SEM, where an asterisk denotes signiﬁcant difference
(p < .05) between Pax7Cre Yapﬂ/1 and Pax7Cre Yapﬂ/ﬂ using a Student’s t test. Scale bar5 100 mm. Abbreviations: CTX, cardiotoxin;
DAPI, 40,6-diamidino-2-phenylindole; IP, intraperitoneal; MyHC, myosin heavy chain; TA, tibialis anterior.
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Figure 6. Genes regulated by TAZ S89A or YAP S127A and proteins bound by TAZ and/or YAP. (A): Venn diagram displaying the number
of genes modulated by TAZ S89A and/or YAP S127A versus control retrovirus (up-reg: upregulated; down-reg: downregulated) at either
24 or 48 hours. (B): Expression fold change for genes that were regulated by both TAZ S89A and YAP S127A in transduced satellite cell-
derived myoblasts versus control retrovirus at either 24 or 48 hours. (C): Expression fold change for genes that were regulated only by
TAZ S89A at either 24 or 48 hours. (D): All TAZ and/or YAP interacting proteins identiﬁed by mass spectrometry in C2C12 myoblasts and
myotubes. Those previously identiﬁed are in red [53] and novel proteins in black, with those of particular interest in blue. To minimize
false positives, selected cut-off values were a ratio of 2 compared with empty vector and p < .05 Student’s t test between each data-
set and control vector. Abbreviations: IGF, insulin-like growth factor; mTOR, • • •.
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in myoblasts (Fig. 6C), again highlighting the switch from pro-
moting proliferation toward cell cycle withdrawal/
differentiation.
YAP and TAZ Bind Both Common and Unique Proteins
Apart from Tead1-4, Yap and Taz also bind a plethora of
upstream signaling proteins and downstream transcriptional
regulators [52]. To identify binding partners in a non-biased
way, we expressed ﬂag-tagged WT human YAP or TAZ in pro-
liferating murine C2C12 myoblasts and mature myotubes.
Flag-immunoprecipitated YAP or TAZ complexes were identi-
ﬁed using mass-spectrometry (Fig. 6D; Supporting Information
Data 2).
Our TAZ and YAP binding proteins were ﬁrst validated
against previously characterized binding partners in human
embryonic kidney 293T cells [53]. Overlap included angiomo-
tins, multiple 14-3-3 proteins, Tead1, Tead3, and Tead4 (red:
Fig. 6D). However, we also identiﬁed many novel TAZ and/or
YAP interacting proteins in myogenic cells (Fig. 6D). TAZ bound
many more proteins in myoblasts than YAP, or that were com-
mon to both YAP and TAZ. In myotubes, however, YAP bound
many more proteins than TAZ or both TAZ and YAP, with only
YAP binding Wnt regulators Dvl2 and Dvl3. Of 26 TAZ and YAP
binding proteins in mature myotubes (Fig. 6D), 10 are linked
to actin cytoskeleton and the Chaperone assisted selective
autophagy (CASA) complex, including the WW-domain con-
taining Bag3. We also identiﬁed 20 proteins bound speciﬁcally
by TAZ during differentiation, the majority associated with the
actin cytoskeleton and myogenesis including Unc45a and Fhl3
[54, 55]. MyoD was not among YAP and/or TAZ binding part-
ners, even at less stringent cut-offs.
TAZ Operates through Tead4 to Control Myogenic
Differentiation
We next assayed Tead expression during myogenesis. TA mus-
cle was injured using CTX and mRNA isolated from regenerat-
ing muscle after 1, 3, 5, 7, and 14 dpi. RT-qPCR showed that
Tead2 and Tead4 exhibited similar expression proﬁles, peaking
around day 3, before falling to levels seen in undamaged
muscle (Fig. 7A). Tead1-3 mRNA was at a constant level in
proliferating and differentiating C2 myoblasts, but Tead4
expression increased robustly at the onset of myogenic differ-
entiation, being maintained at elevated levels through fusion
(Fig. 7B). Western blot revealed that Tead1 and Tead4 protein
levels increased upon entry into C2C12 myoblast differentia-
tion and were maintained (Fig. 7C).
As Tead4 is critical for myoblast fusion due to inducing
myogenin by binding MCAT elements in its promoter [56], we
further examined its function. Coimmunolabeling of Tead4
and Taz showed both proteins present in the nucleus of differ-
entiating myoblasts, at a time when Tead4 levels rise mark-
edly (Fig. 7D). Thus, the TAZ-Tead4 interaction identiﬁed in
proliferating myoblasts (but not in mature myotubes) (Fig. 6D)
could be maintained during induction and the early phases of
myogenic differentiation, not assayed by proteomics.
We used retroviral-mediated expression to enhance TAZ
activity and/or siRNA to reduce Tead4 levels in satellite cell-
derived myoblasts during myogenic differentiation, and
assayed fusion index after coimmunolabeling for eGFP/MyHC.
TAZ S89A with control siRNA augmented myoblast fusion (Fig.
7E, 7F), but TAZ S89A with concomitant Tead4 knockdown
reversed this enhanced fusion index (Fig. 7E, 7F). Knockdown
of Tead4 alone resulted in shorter and thinner myotubes,
reﬂected in a reduced fusion index, but expression of TAZ
S89A did allow recover of the fusion index back to control
levels (Fig. 7E, 7F).
To investigate the role of TAZ/Tead4 in entry into myo-
genic differentiation versus fusion, we also transduced satel-
lite cell-derived myoblasts with TAZ S89A and/or transfected
with Tead4 siRNA and differentiated cells as myocytes. After
24 hours in differentiation medium, coimmunolabeling
revealed that TAZ S89A increased the proportion of eGFP-
expressing cells containing myogenin, compared with controls.
Knockdown of Tead4 alone signiﬁcantly reduced myogenin
expression (Fig. 7G, 7H). Simultaneous expression of TAZ S89A
and Tead4 siRNA knockdown though, brought the proportion
of GFP-expressing myoblasts containing myogenin back to
control levels (Fig. 7G, 7H).
DISCUSSION
Yap, Taz, and Tead1-4 constitute a dynamic system in satellite
cells and the muscle lineage, with mRNA and protein levels of
some changing extensively during muscle regeneration and
myogenic differentiation in vitro. Three are of note: Yap [29]
and Taz only become detectable during satellite cell activa-
tion, suggesting that Yap and Taz only operate during myogen-
esis; mRNA/protein levels of some Teads also change,
suggesting that Teads are not just static targets of Yap/Taz;
Taz and Tead4 increase dramatically during myogenic differen-
tiation, while Yap expression remains fairly constant. During
regeneration, Taz and Tead4 levels peak around 3–5 dpi, as
myogenic differentiation is underway [57–59]. Our observa-
tions are consistent with Taz and Tead4 as pro-differentiation
factors [28, 29, 37, 56].
Manipulation of Yap and Taz activity/levels via retroviral-
mediated expression of WT or TAZ S89A, or knockdown of
Taz, revealed that TAZ promotes proliferation. Yap [28, 29]
and Taz synergistically promote proliferation in many cell
types [60], with a recent ChIP-Seq study in breast cancer cells
showing that YAP and TAZ frequently operate through the
same enhancer elements [24]. Later, in myogenesis, however,
TAZ switches to promote differentiation, in accordance with
an earlier reports in immortalized murine myoblasts [37, 38],
unlike YAP, which inhibits differentiation [28, 29]. TAZ actually
augments the myogenic differentiation program under differ-
entiation stimuli, as shown by the precocious expression of
myogenin in many myocytes. Thus, the greater fusion index
with TAZ overexpression is not merely due to having more
myoblasts available, due to the proproliferation effects of TAZ.
Consistent with its later pro-differentiation role, constitutive
TAZ expression also reduced self-renewal of satellite cells,
while Taz (Wwtr1–/–)-null satellite cells exhibited reduced
fusion ex vivo.
Taz (Wwtr1–/–)-null mice have functional and growth
defects in kidneys and other organs, consistent with Taz as a
regulator of organ growth and transcriptional regulator of
genes involved in heart, lung, and bone growth [21, 61, 62].
Taz (Wwtr1–/–)-null mice were generally lighter, with TA,
soleus, EDL, and gastrocnemius muscle mass all reduced, but
with unchanged numbers of satellite cells and myonuclei per
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Figure 7. TAZ operates through Tead4 to control myogenic differentiation. (A): Tead2–4 mRNA expression in regenerating tibialis ante-
rior (TA) muscle collected at 1, 3, 5, 7, and 14 days post injury with cardiotoxin. Expression is presented as fold change compared with
control undamaged TA (n 5 3). (B): Tead1–4 mRNA levels in C2C12 myoblasts at 24 and 48 hours in proliferation medium, and 24, 48,
72, and 96 hours in differentiation medium, expressed as fold change compared with 24 hours proliferation time-point (n 5 3). (C):
Representative Western blots of C2C12 myoblast lysate collected at 24 and 48 hours in proliferation medium and 24, 48, 72, and 96
hours in differentiation medium and immunoblotted for Yap, Taz, Tead1 (biological replicate 3), phosphorylated Yap and Taz (biological
replicate 2) and Tead4 (biological replicate 1) (n 5 4), with relevant a-Tubulin or Gapdh loading controls. (D): Representative images of
plated satellite cell-derived myoblasts coimmunolabeled with Tead4 and Taz cultured under differentiation conditions for 24 hours. (E):
Representative images of coimmunolabeling of myotubes formed from satellite cell-derived myoblasts following TAZ S89A or control vec-
tor (RV) transduction and/or small interfering RNA (siRNA) knockdown of Tead4 or siRNA control. Green ﬂuorescent protein (GFP) labels
transduced cells and myosin heavy chain (MyHC) identiﬁes myotubes. (F): Comparison of the proportion of nuclei in GFP1ve/MyHC1ve
myotubes under each condition shows that TAZ requires Tead4 to enhance differentiation (n 5 3 mice). (G): Representative images of
coimmunolabeling of myocytes formed from satellite cell-derived myoblasts following TAZ S89A or RV transduction and/or siRNA knock-
down of Tead4 or siRNA control, and 24 hours in differentiation medium. GFP labels transduced cells and Myogenin identiﬁes myocytes.
(H): Comparison of the proportion of GFP1ve/Myogenin1ve myocytes under each condition shows that TAZ-induced myogenic differen-
tiation operates through Tead4 (n 5 3 mice). Data are mean 6 SEM from three mice, where an asterisk denotes signiﬁcant difference
(p < .05) from RV/siRNA Control, or as indicated by bars, using a paired Student’s t test. Scale bar5 100 mm. Abbreviations: DAPI, 40,6-
diamidino-2-phenylindole; GFP, green ﬂuorescent protein; MyHC, myosin heavy chain; RV, control vector; siRNA, small interfering RNA.
myoﬁber. However, absence of Taz reduced the total number
of myoﬁbers in soleus, with both fewer slow type I and fast
Type IIa muscle ﬁbers present, although there was a greater
proportion of slow type I myoﬁbers.
Lack of an overt muscle regeneration phenotype in Taz
(Wwtr1–/–)-null mice could be due to compensation by Yap in pro-
moting satellite cell proliferation, as Yap or Taz knockdown did not
affect expression of the other gene [63]. In comparison, genetic
deletion of Yap speciﬁcally in satellite cells caused delayed regen-
eration, so Taz is unable to compensate for Yap in early regenera-
tion. This regeneration defect in tamoxifen-treated Pax7Cre-ERT2/1:
Yapﬂ8x/ﬂ8x:Rosa26Lacz mice was transient although, maybe due to
Taz promoting myogenic differentiation later in regeneration.
Therefore, skeletal muscle joins other systems where Yap is
required for regeneration, for example, where defects in crypt
regeneration are observed when Yap is inactivated in epithelium
of the small intestine, and in the skin [64–66].
We also examined gene expression in myoblasts in response
to TAZ S89A or YAP S127A. As expected, YAP and TAZ increased
expression of Hippo marker gene Cyr61 and Hippo negative-
feedback loop genes Lats2, Frmd6 (Willin), and Amotl2: a typical
response to increased Taz and Yap activity [29]. Intriguingly, TAZ
also downregulates Bag3, a WW domain-containing member of
the CASA mechanosensitive Z-disc linked complex [67] that
binds to Yap and Taz, and Yes1, the earliest reported binding
partner of Yap [68]. Bag3 and Yes1 might represent additional
members of the Hippo negative feedback loop in myoblasts.
Several TAZ- and YAP-regulated genes have been linked to myo-
genesis. For example, TAZ and YAP reduced expression of Six1
and Six4, two factors controling migration of muscle precursor
cells [69] with a role in muscle regeneration [70]. TAZ and YAP
also regulated many IGF/mTOR-related genes (Ndrg2, Igfbp5,
Irs2, and Igf2bp1), conﬁrming crosstalk between Hippo and
mTOR signaling [2, 3].
TAZ also regulates a unique cohort of genes, including
Pax7, whose expression was reduced by TAZ S89A, consistent
with the switch toward differentiation. TAZ also modulates
multiple olfactory receptor genes, whose levels vary between
mdx and control mice [51], and a family of genes that can
affect muscle regeneration [71].
TAZ and YAP bind proteins in murine myoblasts/myotubes
that have been identiﬁed as binding partners in human 293T
cells [53]. These generic YAP and TAZ binding proteins include
the angiomotins (Amot and Amotl1), Tead1 and Tead4 and sev-
eral 14-3-3 proteins (Ywhae, Ywhag, Ywhaz). Additionally, we
identiﬁed many novel TAZ and/or YAP binding partners in the
skeletal muscle lineage, including in myotubes, Bag3 [72] and
syncoilin (Sync), an intermediate ﬁlament protein linked to the
dystrophin-associated protein complex [73]. TAZ-speciﬁc binding
partners that could potentially explain pro-differentiation
effects include Fhl3, which binds MyoD to inhibit differentiation
[55] and Unc45a, which increases muscle cell proliferation and
fusion, and when inhibited, blocks muscle cell fusion [54].
Runx1 bound to TAZ in myoblasts and downregulation of Runx1
leads to cell cycle exit and differentiation [54]. Taz has been
reported to bind MyoD using immunoprecipitation assays [37],
but while we observed MyoD and Taz in the same nuclei, we
found no signiﬁcant direct interaction using mass spectrometry.
Our combined gene expression and binding partner analy-
ses in myoblasts reveals that YAP or TAZ does not bind members
of the Wnt destruction complex [8]. YAP bound the disheveled
proteins Dvl2 and Dvl3 in myotubes, relevant as Dvl2 can affect
satellite cell polarity and migration downstream of Wnt7a/Fzd7
[74]. TAZ S89A downregulates Fzd6 and Fzd7, and Lgr4, Lgr5,
and Lgr6, important Wnt receptors in developmental and regen-
erative myogenesis [75, 76], suggesting that TAZ desensitize
cells to ligands that bind these receptors. For example, quies-
cent satellite cells express high levels of Fzd7 but not Taz or Yap,
but during activation, the increased abundance/activity of Yap/
Taz could be involved in the down-regulation of Fdz7.
Additionally, TAZ S89A increases expression of Wnt4,
decreases Sox9 expression and alters expression of secreted
Wnt-associated proteins and genes encoding the structurally
related proteins Wisp1, Wisp2, Igfbp4, Cyr61, and Bmp4 [49].
Many of these genes have been implicated in regulation of
developmental myogenesis, satellite cell function and muscle
ﬁbers. For example, over-expression of Wnt4 increased Pax7
and MyoD1 expression in chick embryos [77]. Bmp4 promotes
satellite cell proliferation but inhibits differentiation [78].
Interestingly, Tead4 bound TAZ and YAP in proliferating
myoblasts but not in mature multinucleated myotubes. Tead4
increases dramatically as myoblasts enter myogenic differenti-
ation and levels are then maintained. Thus the TAZ-Tead4
interaction identiﬁed in proliferating myoblasts by proteomics
is likely maintained during induction and the early phases of
myogenic differentiation, not assayed by proteomics. When
Tead4 was knocked down, myogenic differentiation was sup-
pressed, which recovered to controls levels when TAZ S98A
was also expressed. However, TAZ S89A could no longer
enhance entry into the differentiation programme and aug-
ment fusion when Tead4 levels were reduced. Thus, the role
of TAZ in inducing and promoting myogenic differentiation is
linked to interaction with Tead4 [37, 56].
CONCLUSION
In conclusion, in the skeletal myogenic lineage, we demon-
strate similar roles of TAZ and YAP in promoting myoblast pro-
liferation, but during the later stages of myogenesis, Taz
switches toward inﬂuencing satellite cell fate by promoting
myogenic differentiation.
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